Vis enkel innførsel

dc.contributor.authorKisa, Adnan
dc.contributor.authorBourne, Rupert RA
dc.contributor.authorSteinmetz, Jaimie D
dc.contributor.authorFlaxman, Seth R
dc.contributor.authorBriant, Paul Svitil
dc.contributor.authorTaylor, Hugh R
dc.contributor.authorKisa, Sezer
dc.contributor.authorVos, Theo
dc.contributor.authorWest, Sheila K
dc.contributor.authorJonas, Jost B.
dc.date.accessioned2020-12-02T20:47:28Z
dc.date.accessioned2021-02-17T05:51:40Z
dc.date.available2020-12-02T20:47:28Z
dc.date.available2021-02-17T05:51:40Z
dc.date.issued2020-12-01
dc.identifier.citationKisa A, Bourne RR, Steinmetz, Flaxman SR, Briant, Taylor HR, Vision Impairment Collaborator, Kisa S, Vos T, West, Jonas JB. Trends in prevalence of blindness and distance and nearvision impairment over 30 years: an analysis for the GlobalBurden of Disease Study. The Lancet Global Health. 2020en
dc.identifier.issn2572-116X
dc.identifier.issn2214-109X
dc.identifier.urihttps://hdl.handle.net/10642/9580
dc.description.abstractBackground To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of global vision impairment in 2020 and temporal change is needed. We aimed to extensively update estimates of global vision loss burden, presenting estimates for 2020, temporal change over three decades between 1990–2020, and forecasts for 2050. Methods We did a systematic review and meta-analysis of population-based surveys of eye disease from January, 1980, to October, 2018. Only studies with samples representative of the population and with clearly defined visual acuity testing protocols were included. We fitted hierarchical models to estimate 2020 prevalence (with 95% uncertainty intervals [UIs]) of mild vision impairment (presenting visual acuity ≥6/18 and <6/12), moderate and severe vision impairment (<6/18 to 3/60), and blindness (<3/60 or less than 10° visual field around central fixation); and vision impairment from uncorrected presbyopia (presenting near vision <N6 or <N8 at 40 cm where best-corrected distance visual acuity is ≥6/12). We forecast estimates of vision loss up to 2050. Findings In 2020, an estimated 43·3 million (95% UI 37·6–48·4) people were blind, of whom 23·9 million (55%; 20·8–26·8) were estimated to be female. We estimated 295 million (267–325) people to have moderate and severe vision impairment, of whom 163 million (55%; 147–179) were female; 258 million (233–285) to have mild vision impairment, of whom 142 million (55%; 128–157) were female; and 510 million (371–667) to have visual impairment from uncorrected presbyopia, of whom 280 million (55%; 205–365) were female. Globally, between 1990 and 2020, among adults aged 50 years or older, age-standardised prevalence of blindness decreased by 28·5% (–29·4 to –27·7) and prevalence of mild vision impairment decreased slightly (–0·3%, –0·8 to –0·2), whereas prevalence of moderate and severe vision impairment increased slightly (2·5%, 1·9 to 3·2; insufficient data were available to calculate this statistic for vision impairment from uncorrected presbyopia). In this period, the number of people who were blind increased by 50·6% (47·8 to 53·4) and the number with moderate and severe vision impairment increased by 91·7% (87·6 to 95·8). By 2050, we predict 61·0 million (52·9 to 69·3) people will be blind, 474 million (428 to 518) will have moderate and severe vision impairment, 360 million (322 to 400) will have mild vision impairment, and 866 million (629 to 1150) will have uncorrected presbyopia.en
dc.description.sponsorshipBrien Holden Vision Institute, Fondation Thea, Fred Hollows Foundation, Bill & Melinda Gates Foundation, Lions Clubs International Foundation, Sightsavers International, and University of Heidelberg.en
dc.language.isoenen
dc.publisherElsevieren
dc.relation.ispartofseriesThe Lancet Global Health;
dc.rightsCreative Commons Attribution 4.0 International (CC BY 4.0) licenseen
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectNear vision impairmentsen
dc.subjectSystematic reviewsen
dc.subjectEye diseasesen
dc.subjectBlindnessen
dc.titleTrends in prevalence of blindness and distance and nearvision impairment over 30 years: an analysis for the GlobalBurden of Disease Studyen
dc.typeJournal articleen
dc.typePeer revieweden
dc.date.updated2020-12-02T20:47:28Z
dc.description.versionpublishedVersionen
dc.identifier.doihttps://doi.org/10.1016/S2214-109X(20)30425-3
dc.identifier.cristin1855551
dc.source.journalThe Lancet Global Health


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Creative Commons Attribution 4.0 International (CC BY 4.0) license
Med mindre annet er angitt, så er denne innførselen lisensiert som Creative Commons Attribution 4.0 International (CC BY 4.0) license